Cargando…

Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial

INTRODUCTION: The promotion of a healthy diet, physical activity and measurement of blood glucose levels are essential components in the care for women with gestational diabetes mellitus (GDM). Smartphones offer a new way to promote health behaviour. The main aim is to investigate if the use of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgen, Iren, Garnweidner-Holme, Lisa Maria, Jacobsen, Anne Flem, Bjerkan, Kirsti, Fayyad, Seraj, Joranger, Pål, Lilleengen, Anne Marie, Mosdøl, Annhild, Noll, Josef, Småstuen, Milada Cvancarova, Terragni, Laura, Torheim, Liv Elin, Lukasse, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372027/
https://www.ncbi.nlm.nih.gov/pubmed/28348183
http://dx.doi.org/10.1136/bmjopen-2016-013117
_version_ 1782518542926610432
author Borgen, Iren
Garnweidner-Holme, Lisa Maria
Jacobsen, Anne Flem
Bjerkan, Kirsti
Fayyad, Seraj
Joranger, Pål
Lilleengen, Anne Marie
Mosdøl, Annhild
Noll, Josef
Småstuen, Milada Cvancarova
Terragni, Laura
Torheim, Liv Elin
Lukasse, Mirjam
author_facet Borgen, Iren
Garnweidner-Holme, Lisa Maria
Jacobsen, Anne Flem
Bjerkan, Kirsti
Fayyad, Seraj
Joranger, Pål
Lilleengen, Anne Marie
Mosdøl, Annhild
Noll, Josef
Småstuen, Milada Cvancarova
Terragni, Laura
Torheim, Liv Elin
Lukasse, Mirjam
author_sort Borgen, Iren
collection PubMed
description INTRODUCTION: The promotion of a healthy diet, physical activity and measurement of blood glucose levels are essential components in the care for women with gestational diabetes mellitus (GDM). Smartphones offer a new way to promote health behaviour. The main aim is to investigate if the use of the Pregnant+ app, in addition to standard care, results in better blood glucose levels compared with current standard care only, for women with GDM. METHODS AND ANALYSIS: This randomised controlled trial will include 230 pregnant women with GDM followed up at 5 outpatient departments (OPD) in the greater Oslo Region. Women with a 2-hour oral glucose tolerance test (OGTT) ≥9 mmol/L, who own a smartphone, understand Norwegian, Urdu or Somali and are <33 weeks pregnant, are invited. The intervention group receives the Pregnant+ app and standard care. The control group receives standard care only. Block randomisation is performed electronically. Data are collected using self-reported questionnaires and hospital records. Data will be analysed according to the intention-to-treat principle. Groups will be compared using linear regression for the main outcome and χ(2) test for categorical data and Student's t-test or Mann-Whitney-Wilcoxon test for skewed distribution. The main outcome is the glucose level measured at the 2-hour OGTT 3 months postpartum. Secondary outcomes are a change in health behaviour and knowledge about GDM, quality of life, birth weight, mode of delivery and complications for mother and child. ETHICS AND DISSEMINATION: The study is exempt from regional ethics review due to its nature of quality improvement in patient care. Our study has been approved by the Norwegian Social Science Data Services and the patient privacy protections boards governing over the recruitment sites. Findings will be presented in peer-reviewed journals and at conferences. TRIAL REGISTRATION NUMBER: NCT02588729, Post-results.
format Online
Article
Text
id pubmed-5372027
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53720272017-04-12 Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial Borgen, Iren Garnweidner-Holme, Lisa Maria Jacobsen, Anne Flem Bjerkan, Kirsti Fayyad, Seraj Joranger, Pål Lilleengen, Anne Marie Mosdøl, Annhild Noll, Josef Småstuen, Milada Cvancarova Terragni, Laura Torheim, Liv Elin Lukasse, Mirjam BMJ Open Diabetes and Endocrinology INTRODUCTION: The promotion of a healthy diet, physical activity and measurement of blood glucose levels are essential components in the care for women with gestational diabetes mellitus (GDM). Smartphones offer a new way to promote health behaviour. The main aim is to investigate if the use of the Pregnant+ app, in addition to standard care, results in better blood glucose levels compared with current standard care only, for women with GDM. METHODS AND ANALYSIS: This randomised controlled trial will include 230 pregnant women with GDM followed up at 5 outpatient departments (OPD) in the greater Oslo Region. Women with a 2-hour oral glucose tolerance test (OGTT) ≥9 mmol/L, who own a smartphone, understand Norwegian, Urdu or Somali and are <33 weeks pregnant, are invited. The intervention group receives the Pregnant+ app and standard care. The control group receives standard care only. Block randomisation is performed electronically. Data are collected using self-reported questionnaires and hospital records. Data will be analysed according to the intention-to-treat principle. Groups will be compared using linear regression for the main outcome and χ(2) test for categorical data and Student's t-test or Mann-Whitney-Wilcoxon test for skewed distribution. The main outcome is the glucose level measured at the 2-hour OGTT 3 months postpartum. Secondary outcomes are a change in health behaviour and knowledge about GDM, quality of life, birth weight, mode of delivery and complications for mother and child. ETHICS AND DISSEMINATION: The study is exempt from regional ethics review due to its nature of quality improvement in patient care. Our study has been approved by the Norwegian Social Science Data Services and the patient privacy protections boards governing over the recruitment sites. Findings will be presented in peer-reviewed journals and at conferences. TRIAL REGISTRATION NUMBER: NCT02588729, Post-results. BMJ Publishing Group 2017-03-27 /pmc/articles/PMC5372027/ /pubmed/28348183 http://dx.doi.org/10.1136/bmjopen-2016-013117 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Diabetes and Endocrinology
Borgen, Iren
Garnweidner-Holme, Lisa Maria
Jacobsen, Anne Flem
Bjerkan, Kirsti
Fayyad, Seraj
Joranger, Pål
Lilleengen, Anne Marie
Mosdøl, Annhild
Noll, Josef
Småstuen, Milada Cvancarova
Terragni, Laura
Torheim, Liv Elin
Lukasse, Mirjam
Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
title Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
title_full Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
title_fullStr Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
title_full_unstemmed Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
title_short Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
title_sort smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372027/
https://www.ncbi.nlm.nih.gov/pubmed/28348183
http://dx.doi.org/10.1136/bmjopen-2016-013117
work_keys_str_mv AT borgeniren smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT garnweidnerholmelisamaria smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT jacobsenanneflem smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT bjerkankirsti smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT fayyadseraj smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT jorangerpal smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT lilleengenannemarie smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT mosdølannhild smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT nolljosef smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT smastuenmiladacvancarova smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT terragnilaura smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT torheimlivelin smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial
AT lukassemirjam smartphoneapplicationforwomenwithgestationaldiabetesmellitusastudyprotocolforamulticentrerandomisedcontrolledtrial